Filter
405
Filtered Results: 405
Text search:
GAVI
The
Vaccine
Alliance
Featured
Recommendations
39
New Publications
107
Language
Document type
No document type
178
Studies & Reports
106
Strategic & Response Plan
54
Guidelines
28
Manuals
19
Fact sheets
12
Situation Updates
6
Training Material
2
Countries / Regions
Global
47
Liberia
17
Sierra Leone
14
Kenya
12
Nigeria
10
Nepal
9
Africa
9
Ghana
6
Congo, Democratic Republic of
6
South–East Asia Region
6
Western and Central Europe
6
Uganda
6
Myanmar / Burma
6
Malawi
5
Guinea
5
East and Southern Africa
5
Bangladesh
5
Ethiopia
5
Zambia
5
Syria
4
Burkina Faso
4
Latin America and the Carribbean
4
West and Central Africa
4
Middle East and North Africa
4
Pakistan
4
Senegal
3
Zimbabwe
3
Cambodia
3
Asia
3
South Sudan
3
India
3
Rwanda
2
Afghanistan
2
Tanzania
2
Eastern Europe and Central Asia
2
South Africa
2
Brazil
2
Namibia
2
Central African Republic
2
Mali
2
Somalia
2
Madagascar
2
Colombia
1
Timor Leste/ East Timor
1
Ukraine
1
Lesotho
1
Benin
1
China
1
Cameroon
1
USA
1
Haiti
1
Germany
1
Japan
1
Eastern Europe
1
Yemen
1
Botswana
1
Indonesia
1
Iraq
1
Authors & Publishers
Publication Years
Category
Countries
129
Clinical Guidelines
37
Women & Child Health
29
Public Health
21
Key Resources
15
Pharmacy & Technologies
3
Capacity Building
2
Toolboxes
COVID-19
59
Health Financing Toolbox
48
Rapid Response
24
AMR
22
Ebola & Marburg
18
Global Health Education
18
Polio
15
Planetary Health
8
Pharmacy
7
HIV
6
Mental Health
5
Refugee
5
NTDs
5
TB
4
Disability
3
Cholera
3
Caregiver
3
NCDs
3
Conflict
3
The document will provide information for Ministries of Health and hospital sentinel sites on why and how to determine the denominator of at-risk children <5 years of age and rate of meningitis hospitalizations for a sentinel hospital site conducting IB-VPD surveillance. Such a methodology is curren...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i...
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
The African Centers for Disease Control and Prevention and the African Union together have called for a New Public Health Order which will safeguard the health and economic security of the continent as it strives to meet the aspirations of the Agenda 2063. A key pillar of this mandate seeks to expan...
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the man...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards
the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized ...
The current SEARVAP (South-East Asia regional vaccine action plan) describes a set of regional goals and objectives for immunization and control of vaccine-preventable diseases for 2016 – 2020 and highlights priority actions, targets and indicators that address the specific needs and challenges of...
Long-term polio vaccine security – the timely, sustained, and uninterrupted supply of suitable types of affordable, quality-assured polio vaccines – is essential in the global effort to achieve and maintain a polio free world. However, fragmented approaches and short-term planning pose considera...
A lack of knowledge about the threat of vaccine-preventable diseases, risks and benefits of vaccines, mistrust of government and health workers, poor service delivery and alternative health or religious beliefs play a role in lower uptake of some vaccines. These challenges underscore the importance ...
This guide is intended to support national governments developing their national deployment and vaccination plans (NDVPs) for COVID-19 vaccines by outlining the roles, needs and opportunities for community health workers (CHWs) to contribute. This note builds on and is structured to align with the G...
Rabies is entirely preventable, and vaccines, medicines, tools and technologies have long
been available to prevent people from dying of dog-mediated rabies. Nevertheless, rabies still
kills about 60 000 people a year, of whom over 40% are children under 15, mainly in rural areas
of economically ...
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment ...
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19 vacci...
The roadmap describes the actions needed to
achieve the three development goals for TB
vaccines set by the WHO:
1. A safe, effective and affordable TB vaccine
for adolescents and adults.
2. An affordable TB vaccine for neonates and
infants with improved safety and efficacy.
3. A therapeutic v...
an operational guide to support all those responsible for planning and implementing the rollout of COVID-19 vaccine to refugees and migrants at national and local levels, 14 March 2022
The Guidance on National Deployment and Vaccination Planning is intended to help countries develop their plan for COVID-19 vaccine introduction.
Available in English, French, Portuguese and Arabic
Successful immunization of a critical mass of the African population with one or several safe and efficacious COVID-19 vaccines.Key objectives1. Accelerate African involvement in the clinical development of a vaccine. 2. Ensur...
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID...
Will COVID-19 vaccines be safe? Will all the COVID-19 candidate vaccines be successful? What are the different phases a vaccine must go through to be approved? This document provides responses to the most frequently asked questions about candidate vaccines and access to COVID-19 vaccination.
An estimated 59 000 people die from rabies each year. That’s one person every nine minutes of every day, 40% of whom are children living in Asia and Africa. As dog bites cause almost all human cases, we can prevent rabies deaths by increasing awareness, vaccinating dogs to prevent the disease at i...
